Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo study

Articolo
Data di Pubblicazione:
2008
Citazione:
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo study / Galimberti, S; Canestraro, M; Ciancia, E; Fazzi, R; Marasca, Roberto; Petrini, M.. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - STAMPA. - 32:8(2008), pp. 1324-1325. [10.1016/j.leukres.2007.11.027]
Abstract:
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: An ex vivo study
Tipologia CRIS:
Articolo su rivista
Keywords:
Idiopathic myelofibrosis; bortezomib; angiogenesis
Elenco autori:
Autori di Ateneo:
Link alla scheda completa:
https://iris.unimore.it/handle/11380/608919
Pubblicato in:
LEUKEMIA RESEARCH
Journal